MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-04-0102597
Promediate Pharmaceuticals Private Limited
Promediate Pharmaceuticals Private Limited - chemicals in Aurangabad, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹7.2 Lakh
▼ 30% YoY
Net profit · FY 2025
₹1,538
Net margin 0.2%
EBITDA · FY 2025
₹33,318
EBITDA margin 4.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Promediate Pharmaceuticals Private Limited
Data last updated:
Promediate Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 14 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2020PTC337729.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Proate Pharmaceuticals Private Limited. It is led by directors Sanjay Ratnakarrao Aknikar and Deepak Divakarrao Akanikar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rh – 120/A2 Bajaj Nagar MIDC Waluj Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.2 Lakh, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹1,538 (net margin 0.2%) and EBITDA of ₹33,318 (EBITDA margin 4.6%). Revenue has grown at a compounded annual rate (CAGR) of 53% over three years.
Promediate Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-04-0102597).
Company details
CIN U24230MH2020PTC337729
Registration Number 337729
Incorporation Date 14 February 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-04-0102597
Recognitions & Rankings of Promediate Pharmaceuticals
Contact details
Promediate Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra.
- Registered AddressRh – 120/A2 Bajaj Nagar MIDC Waluj Aurangabad, Maharashtra, India – 431001
- IndustryChemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Promediate Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Promediate Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Promediate Pharmaceuticals Private Limited, buy the company report.
Financials of Promediate Pharmaceuticals Private Limited
FY 2025 filings availablePromediate Pharmaceuticals Private Limited reported revenue of ₹7.2 Lakh (down 30% YoY) for FY 2025.
Revenue · FY 2025
₹7.2 Lakh ▼ 30%
Net profit · FY 2025
₹1,538 margin 0.2%
EBITDA · FY 2025
₹33,318 margin 4.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 30%
3 years · compounded
▲ 53%
EBITDA CAGR growth
1 year
▼ 79%
3 years · compounded
▲ 30%
Revenue fell 30% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 53%. EBITDA fell 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33,318 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,538 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Promediate Pharmaceuticals Private Limited, buy the company report.
Board of directors of Promediate Pharmaceuticals Private Limited
Promediate Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Ratnakarrao Aknikar | Director | 14 Feb 2020 | 6 Years 8 Months | Current |
| Deepak Divakarrao Akanikar | Director | 07 Jul 2022 | 4 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Promediate Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Promediate Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Promediate Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Promediate Pharmaceuticals Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Deepak Divakarrao Akanikar ceased to be Additional Director on 29 Sep 2023.
AGM
Promediate Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Promediate Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Deepak Divakarrao Akanikar ceased to be Additional Director.
Appointed
Deepak Divakarrao Akanikar was appointed as Director.
Ceased
Kishor Diwakar Akanikar ceased to be Director.
Appointed
Sanjay Ratnakarrao Aknikar was appointed as Director.
Incorporation
14 Feb 2020
Promediate Pharmaceuticals Private Limited was registered on 14 Feb 2020 with Roc Mumbai Ii & aged 6 years 8 months as per MCA records.
Frequently asked questions
Promediate Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 14 February 2020 (6+ years old) and is registered under CIN U24230MH2020PTC337729.
Promediate Pharmaceuticals has 2 current directors:
- Sanjay Ratnakarrao Aknikar - Director
- Deepak Divakarrao Akanikar - Director
The latest financial statements of Promediate Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Promediate Pharmaceuticals is U24230MH2020PTC337729. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Promediate Pharmaceuticals was incorporated on 14 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Deepak Divakarrao Akanikar ceased to be Additional Director on 29 Sep 2023. Deepak Divakarrao Akanikar was appointed as Director on 07 Jul 2022. Kishor Diwakar Akanikar ceased to be Director on 07 Jul 2022. Promediate Pharmaceuticals has 4 board changes on record in total.
Yes, Promediate Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-04-0102597).
The registered office of Promediate Pharmaceuticals is at Rh – 120A2 Bajaj Nagar MIDC Waluj Aurangabad, Maharashtra, India – 431001.
Promediate Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Yes. Promediate Pharmaceuticals was formerly known as Proate Pharmaceuticals Private Limited.